Skip to main content
. 2021 Oct 9;13(20):5043. doi: 10.3390/cancers13205043

Table 3.

Comparison of RT treatment factors and dosimetry parameters between VMAT and HT in patient subgroup of RNI with IMN.

Characteristics Heart Left Lung Whole Lung Other Normal Organs
VMAT
(n = 39)
HT
(n = 24)
p-Value VMAT
(n = 39)
HT
(n = 24)
p-Value VMAT
(n = 39)
HT
(n = 24)
p-Value VMAT
(n = 39)
HT
(n = 24)
p-Value
Volume (cc) 544.5 510.8 0.30 949.2 907.1 0.73 2199.0 2089.7 0.45 Mean dose (Gy)
Mean dose (Gy) 4.43 5.80 0.002 10.30 11.23 0.11 6.02 6.82 0.006 Contralateral breast 2.92 3.71 <0.001
V5 (%) 18.31 34.44 <0.001 40.80 54.56 <0.001 22.31 30.48 <0.001 Thyroid 22.08 19.58 0.02
V10 (%) 8.18 17.11 <0.001 28.80 38.93 <0.001 14.36 19.14 <0.001 Trachea 10.93 10.94 0.72
V15 (%) 5.44 9.28 0.004 - - - - - - Esophagus 5.74 8.71 <0.001
V20 (%) 3.82 5.23 0.13 19.21 22.74 0.04 9.69 10.61 0.72
V25 (%) 2.59 2.89 0.61 - - - - - - Maximal dose (Gy)
V30 (%) 1.77 1.60 0.45 - - - - - - Cord 20.19 20.17 0.88